2012
DOI: 10.1016/s1665-2681(19)31411-5
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiological, clinical and laboratory features of chronic hepatitis B infection in a cohort of immigrant and Italian patients from Ferrara, Italy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
10
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 17 publications
2
10
0
Order By: Relevance
“…In contrast, HBV infection is rarely observed in Asian immigrants (16)(17)(18). These data, showing the differences in infection rates due to ethnicity, highlight the epidemiological pattern of the prevalence of HBV based on country of origin (13,(19)(20)(21). Among our participants, more than half had CHB, indication of a previous infection, with a clear majority from Sub-Saharan Africa (10/12 patients).…”
Section: Discussionsupporting
confidence: 57%
“…In contrast, HBV infection is rarely observed in Asian immigrants (16)(17)(18). These data, showing the differences in infection rates due to ethnicity, highlight the epidemiological pattern of the prevalence of HBV based on country of origin (13,(19)(20)(21). Among our participants, more than half had CHB, indication of a previous infection, with a clear majority from Sub-Saharan Africa (10/12 patients).…”
Section: Discussionsupporting
confidence: 57%
“…However, since 2007 no further decrease in HDV prevalence was recorded in Italy, with steady prevalence rates of 8.4% among HBsAg carriers (28). Of note, the reported prevalence of HDV infection was lower, ranging from 1.3 to 5.0% in Italians and from 4.7 to 7.9% in immigrants, in studies providing data from limited geographic regions (29,30). Unlike several HDV prevalence studies in Italy, the data on HDV prevalence in the other three countries bordering Slovenia are scant and outdated because they date back to 1985, 1993, and 1994, respectively (31)(32)(33).…”
Section: Discussionmentioning
confidence: 98%
“…To evaluate whether differences in HDV prevalence across European countries could be at least partially attributed to the use of anti-HDV antibody tests with different analytical characteristics (mainly different analytical specificity), the material and methods sections of published studies (Table 2) were carefully analyzed. Out of 36 eligible studies, the commercially available enzymelinked immunosorbent assay ETI-AB-DELTAK-2 (DiaSorin) was used in nine studies (14,16,19,30,(37)(38)(39)(40)(41) and the Abbott anti-HD radioimmunoassay (Abbott Laboratories, Chicago, IL) and Radim anti-HDVAb (Radim Iberica, Barcelona, Spain) were used in one study each (17,29). Unfortunately, tests used for detecting anti-HDV antibodies were not specified in the majority of eligible studies.…”
Section: Discussionmentioning
confidence: 99%
“…This shows the infectivity potential of HBV carriers infected by (sub)genotypes circulating in endemic regions like East Asia, Africa, Alaska and East Europe [133] . In a recent investigation in Italy, the immigrant population (mostly from Eastern European countries) showed a high prevalence of HBeAg-positivity with a mean age of 31 years [148] . In another study, Dervicevic et al [149] showed the integration of exotic genotypes of HBV with HBeAg-positivity and high viral load among antenatal women in the United Kingdom.…”
Section: Effect Of "Immigro-subgenotype" On Clinical Outcomementioning
confidence: 99%